Association of aplastic anaemia and Fanconi's disease with HLA-DRB1 alleles

International Journal of Immunogenetics

Volumn 35, Issue 6, 2008, Pages 453-456

  Yari, F ^a   Sobhani, M ^a   Vaziri, M Z ^a   Bagheri, N ^a   Sabaghi, F ^a   Talebian, A ^a  

^a IRANIAN BLOOD TRANSFUSION ORGANIZATION   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN;

ADOLESCENT; ADULT; APLASTIC ANEMIA; ARTICLE; BLOOD ANALYSIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FANCONI ANEMIA; FEMALE; GENETIC SUSCEPTIBILITY; HUMAN; IRAN; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ALLELES; ANEMIA, APLASTIC; CHILD; CHILD, PRESCHOOL; FANCONI SYNDROME; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 55949119003     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/j.1744-313X.2008.00810.x     Document Type: Article

References (24)

1. Arnaiz-Villena, A., Martinez-Laso, J., Gomez-Casado, E., Díaz-Campos, N., Santos, P., Martinho, A. et al 1997) Relatedness among Basques, Portuguese, Spaniard and Algerians studies by HLA allelic frequencies and haplotypes. Immunogenetics, 47, 37.
2. Auerbach, A.D. (1993) Fanconi's anemia diagnosis and the diepoxybutane (DEB) test. Experimental Hematology, 21, 731.
3. Baur, M.P. Danilors, J.A. (1980) Population analysis of HLA-A, B, C, DR and other genetic markers. In : Histocompatibility (ed. by Terasaki, P.I.), p. 955. UCLA Tissue Typing Laboratory, Los Angeles, California.
4. Cervenka, J., Arthur, D. Yasis, C. (1981) Mitomycin C test for diagnostic differentiation of idiopathic aplastic anemia and Fanconi's anemia. Pediatrics, 67, 119.
5. Chapuis, B., Von Fliedner, V.E., Jeannet, M., Merica, H., Vuagnat, P., Gratwohl, A. et al 1986) Increased frequency of DR2 in patients with aplastic anaemia and increased DR sharing in their parents. British Journal of Haematology, 63 (1 51.
6. Fanconi, G. (1967) Familial constitutional panmyelocytopathy, Fanconi's anemia (FA). I. Clinical aspects. Seminars in Hematology, 4, 233.
7. Fernandez-Viña, M.A., Gao, X.J., Moraes, M.E., Moraes, J.R., Salatiel, I., Miller, S. et al 1991) Alleles at four HLA class II loci determined by oligonucloetide hybridization and their associations in five ethnic groups. Immunogenetics, 34, 299.
8. Führer, M., Durner, J., Brünnler, G., Götte, H., Deppner, C., Bender-Götze, C. et al 2007) HLA association is different in children and adults with severe acquired aplastic anemia. Pediatric Blood Cancer, 48, 186.
9. Imanishi, T., Akaza, T., Kimura, A., Tokunaga, K. Gojobori, T. (1992) Allele and haplotype frequencies for IUA and complement loci in various ethnic groups. In : HLA 1991. Proceedings of the Eleventh International Histocompatibility Workshop and Conference (ed. by Tsuji, K., Aizawa, M. Sasazuki, T.) p. 1065. UK Oxford Science Publications, Oxford, UK.
10. Kapustin, S.I., Popova, T.I., Lyshchov, A.A., Imyanitov, E.N., Blinov, M.N. Abdulkadyrov, K.M. (2001) HLA-DR4-Ala74 beta is associated with risk and poor outcome of severe aplastic anemia. Annals of Hematology, 80, 66.
11. Klein, J. Sato, A. (2000) The HLA system. New England Journal of Medicine, 343, 702.
12. Lagaay, A.M., D'Amaro, J., Ligthart, G.J., Schreuder, G.M., Van Rood, J.J. Hijmans, W. (1991) Longevity and heredity in humans: association with the human leucocyte antigen phenotype. Annals of the New York Academy of Sciences, 621, 78.
13. Nakao, S., Yamaguchi, M., Saito, M., Yasue, S., Shiobara, S., Matsuda, T. et al 1992) HLA-DR2 predicts a favorable response to cyclosporine therapy in patients with bone marrow failure. American Journal of Hematology, 40, 239.
14. Rani, R., Fernandez-Vina, M.A. Stastny, P. (1998) Association between HLA class II alleles in a north Indian population. Tissue Antigens, 52, 37.
15. Rugman, F.P., Ashby, D. Davies, J.M. (1990) Does HLA-DR predicts response to specific immunosuppressive therapy in aplastic anaemia? British Journal of Haematology, 74, 545.
16. Saunthararajah, Y., Nakamura, R., Nam, J.M., Robyn, J., Loberiza, F., Maciejewski, J.P. et al 2002) HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome. Blood, 100, 1570.
17. Schipper, R.F., D'Amaro, J. Oudshoorn, M. (1996) The probability of finding a suitable related donor for bone marrow transplant in extended families. Blood, 87, 800.
18. Schroeder, T.M., Tilgen, D., Kruger, J. Vogel, F. (1976) Formal genetics of Fanconi's anemia. Human Genetics, 32, 257.
19. Shao, W., Tian, D., Liu, C., Sun, X. Zhang, X. (2000) Aplastic anemia is X associated with HLA-DRB1*1501 in northern Han Chinese. International Journal of Hematology, 71, 350.
20. Swift, M. (1971) Fanconi's anaemia in the genetics of neoplasia. Nature, 230, 370.
21. Usman, M., Adil, S.N., Moatter, T., Bilwani, F., Arian, S. Khurshid, M. (2004) Increased expression of HLA DR2 in acquired aplastic anemia and its impact on response to immunosuppressive therapy. HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome. JPMA: Journal of the Pakistan Medical Association, 54, 251.
22. Yari, F., Sobhani, M., Sabaghi, F., Zaman Vaziri, M., Bagheri, N. Talebian, A. (2008) HLA-DRB1 frequencies in a normal Iranian population and in patients with acute lymphoblastic leukemia. Archives of Medical Research, 39, 205.
23. Young, N.S. (1995) Aplastic anemia. Lancet, 346, 228.
24. Young, N.S. Maciejewski, J. (1997) The pathophysiology of acquired aplastic anemia. New England Journal of Medicine, 336, 1365.